We have previously shown that under diabetic and hypertensive disease conditions, AGEs and angiotensin II are capable of activating TGF-β/Smad3 signaling directly via the ERK/p38 MAP kinase-crosstalk mechanism and indirectly by inducing TGF-β31, 32. Here, SMAD3 is linked to hypertensive disorder.